
Trestle Biotherapeutics YC Application
Trestle Biotherapeutics went through Y Combinator in the Winter 2021 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2021
- Industry
- HealthcareIndustrial Bio
- Team size
- 2
- Status
- Active
- Launched
- 2021
Founders
Ben ShepherdFounder
Alice ChenFounder
What Trestle Biotherapeutics does
We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.
Trestle Biotherapeutics's YC application, reconstructed
Y Combinator application
Trestle Biotherapeutics, Winter 2021 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Trestle Biotherapeutics
Bioengineered kidneys for kidney failure
We are building an implantable tissue that supplements kidney function for patients with end stage renal disease. Once implanted, it reduces or eliminates their need for dialysis and delays the time until transplantation is necessary.
We currently live in San Diego, CA. After YC, we plan to keep the company based here to maintain close ties to our research partners and clinical collaborators.
San Diego is a biotech hub with strong academic and clinical resources. Being here lets us work closely with surgeons and researchers to develop an implantable kidney tissue tailored for patients.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Trestle Biotherapeutics YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Trestle Biotherapeutics's public data (launch notes, founder backgrounds, product description). It shows how a company like Trestle Biotherapeutics would present itself to YC, not the text they submitted.
What YC batch was Trestle Biotherapeutics in?
Trestle Biotherapeutics was part of the Y Combinator Winter 2021 batch.
Who founded Trestle Biotherapeutics?
Trestle Biotherapeutics was founded by Ben Shepherd, Alice Chen.
What does Trestle Biotherapeutics do?
Bioengineered kidneys for patients with kidney failure
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Trestle Biotherapeutics's application, and every other YC batch, is in YC Insights.